SFS
IMVT icon

Sowell Financial Services’s Immunovant IMVT Stock Holding History

Sowell Financial Services’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,092
Closed -$100K – 1569
2021
Q1 		$100K Buy
6,092
+3,958
+185% +$104K ﹤0.01% 1365
2020
Q4 		$99K Buy
+2,134
New +$98.7K ﹤0.01% 1160

Other funds holding IMVT

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sowell Financial Services's IMVT Position: Q2 2021 in Review

Sowell Financial Services sold out of Immunovant (IMVT) in Q2 2021, closing a stake of 6,092 shares — an estimated $100K sold.

Sowell Financial Services first reported a position in IMVT in Q4 2020 and held it in 2 quarters. The position peaked at $100K in Q1 2021. 110 funds tracked by Wall St. Rank hold IMVT as of Q2 2021.

  • Sowell Financial Services reported no remaining Immunovant position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 6,092 Immunovant shares in Q2 2021, an estimated $100K.
  • Sowell Financial Services first reported a position in Immunovant in Q4 2020 and held it in 2 quarters.
  • Sowell Financial Services's Immunovant position peaked at $100K in Q1 2021.
  • 110 funds tracked by Wall St. Rank held Immunovant as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.